I am an attending physician on the Infectious Diseases Service. In my clinical practice, I care for immunocompromised patients with a wide range of bacterial, viral, parasitic and fungal infections. I have a particular interest in the diagnosis and treatment of infections caused by opportunistic fungi, including Cryptococcus species.
The goal of my laboratory research is to investigate how immune cells in the lung recognize and respond to infection by the fungus Cryptococcus neoformans. These studies will help us to understand the cellular and molecular signals that regulate pulmonary immunity to opportunistic fungi and may lead to the development of novel immunotherapies that will improve our treatment of these infections in susceptible patients.
Kamboj M, Brite J, McMillen T, Robilotti E, Herrera A, Sepkowitz K, Babady NE. Potential of real-time PCR threshold cycle (CT) to predict presence of free toxin and clinically relevant C. difficile infection (CDI) in patients with cancer. J Infect. S0163-4453(17):30385-7.
Plate M, Tavarez JK, Subramaniam S, Luke A, McPhee D, Gilbert M, Irizarry E, Skelly M. PHOTO QUIZ. An Unusual Cause of Abdominal Pain and Fever in a Diabetic Patient. Clin Infect Dis. 62(2): 213, 262-3.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more